• Country / Location Selection

United States (US)

Human LPA protein (active)

Human LPA protein (active). GTX00272-pro
Human LPA protein (active). GTX00272-pro
Human LPA protein (active). GTX00272-pro

Cat No. GTX00272-pro


Functional Assay


10 μg ($259)


Application Note

Lipoprotein, a (Lpa) is a lipoprotein subclass. Lpa is assembled at the hepatocyte cell membrane surface, while other scenarios exist with regard to the location of assembly. It mainly exists in plasma. Lpa contributes to the process of atherogenesis. It also may enhance coagulation by inhibiting the function of tissue factor pathway inhibitor. Lpa carries cholesterol and binds atherogenic proinflammatory oxidized phospholipids as a preferential carrier of oxidized phospholipids in human plasma, which attract inflammatory cells to vessel walls and leads to smooth muscle cell proliferation. Moreover, Lpa also is hypothesized to be involved in wound healing and tissue repair, interacting with components of the vascular wall and extra cellular matrix. Besides, Fibronectin (FN) has been identified as an interactor of Lpa, thus a binding ELISA assay was conducted to detect the interaction of recombinant human Lpa and recombinant human FN. Briefly, Lpa were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to FN-coated microtiter wells and incubated for 2h at 37ºC. Wells were washed with PBST and incubated for 1h with anti-Lpa pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37ºC. Finally, add 50 μl stop solution to the wells and read at 450nm immediately. The binding activity of Lpa and FN was in a dose dependent manner.

Observed MW

39 kDa.



Lyophilized powder


Lyophilized from 20 mM Tris (pH 8.0) with 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.01% SKL, 5% Trehalose, Proclin300. Reconstitute with 20 mM Tris and 150 mM NaCl (pH 8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.


For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, store at -20ºC or below. After reconstitution, keep as concentrated solution.Avoid freeze-thaw cycles.


N-terminal His-Tag; Asp4227~Arg4546

Expression System

E. coli


> 95%


< 1 EU/μg




For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.



lipoprotein(a) , AK38 , APOA , LP


The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence. [provided by RefSeq, Dec 2009]


Research Area


Human LPA protein (active). GTX00272-pro

GTX00272-pro Functional Assay Image

Functional ELISA analysis of GTX00272-pro Human LPA protein (active) which can bind immobilized FN protein.

Human LPA protein (active). GTX00272-pro

GTX00272-pro Image

WB analysis of GTX00272-pro Human LPA protein (active).

Human LPA protein (active). GTX00272-pro

GTX00272-pro Image

SDS-PAGE analysis of GTX00272-pro Human LPA protein (active).


There are currently no references for Human LPA protein (active) (GTX00272-pro). Be the first to share your publications with this product.


There are currently no reviews for Human LPA protein (active) (GTX00272-pro). Be the first to share your experience with this product.
Package List Price ($)
$ 259